dr. salani on choosing among iv, ip, and dose-dense chemo regimens in ovarian cancer
Published 4 years ago • 204 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
2:03
dr. wenham on trials evaluating ip, iv, and dose-dense chemotherapy in ovarian cancer
-
0:54
dr. salani on the progression of upfront ovarian cancer treatment
-
6:13
chemotherapy regimens for ovarian cancer
-
1:01
dr. salani discusses neoadjuvant chemotherapy versus primary debulking surgery in ovarian cancer
-
6:20
dose-dense chemotherapy for ovarian cancer; adding bevacizumab
-
1:02
dr. sabbatini on the future of dose-dense therapy in ovarian cancer
-
1:12
dr. kurnit on adjuvant chemotherapy regimens in mucinous ovarian cancer
-
36:12
dose dense chemotherapy as front-line treatment for ovarian cancer - stephen welch
-
1:23
dr. duska on neoadjuvant chemo vs upfront surgery in ovarian cancer
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
1:06
dr. salani on opportunities for precision medicine in cervical cancer
-
2:26
dr. mirza discusses niraparib dose modifications for ovarian cancer patients with low body weight
-
1:15
dr. somer on hesitancy regarding biosimilar use in oncology
-
1:47
can we decrease chemotherapy in ln premenopausal women based on genomic tests?
-
2:44
do you need chemotherapy?
-
5:45
ip chemo vs iv chemo in ovarian cancer - nancy anderson, msn, rn
-
1:33
meet the su2c ovarian cancer catalyst® team
-
33:14
biochemical testing - dr. shereen ezzat
-
2:33
ovarian cancer - yale medicine explains